Art

J-GLOBAL ID：201202246067198553   Reference number：12A0261849

In Vitro Combination Effects of Aztreonam and Aminoglycoside against Multidrug-Resistant Pseudomonas aeruginosa in Japan

日本における多剤耐性Pseudomonas aeruginosaに対するアズトレオナムおよびアミノグリコシドのin vitro併用効果

Author (14)： ARAOKA Hideki (Toranomon Hospital, Tokyo) ,  BABA Masaru (Toranomon Hospital, Tokyo) ,  TATEDA Kazuhiro (Toho Univ. School of Medicine, Tokyo) ,  ISHII Yoshikazu (Toho Univ. School of Medicine, Tokyo) ,  OGURI Toyoko (Kameda Medical Center, Chiba) ,  OKUZUMI Katsuko (Dokkyo Medical Univ. Hospital, Tochigi) ,  OISHI Tsuyoshi (Tokyo Medical Univ. Ibaraki Medical Center, Ibaraki) ,  MORI Shinichiro (National Cancer Center Hospital, Tokyo) ,  MITSUDA Toshihiro (Yokohama City Univ. Hospital, Kanagawa) ,  MORIYA Kyoji (Univ. Tokyo, Tokyo) ,  NAKAMORI Yoshitaka (Misyuku Hospital, Tokyo) ,  OHMAGARI Norio (Shizuoka Cancer Center, Shizuoka, JPN) ,  YAMAGUCHI Keizo (Toho Univ. School of Medicine, Tokyo) ,  YONEYAMA Akiko (Toranomon Hospital, Tokyo)
Material： Japanese Journal of Infectious Diseases  (日本感染症雑誌)
Volume： 65  Issue： 1  Page： 84-87  Publication year： Jan. 30, 2012 
JST Material Number： F0552A  ISSN： 1344-6304  Document type： Article
Article type： 短報  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *Pseudomonas aeruginosa ,...
Semi thesaurus term： gentamicin ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=12A0261849&from=J-GLOBAL&jstjournalNo=F0552A") }}

JST classification (3)： Microbiology(other than viruses)in general  (EG03010C) ,  Basic research of antibacterial drugs  (GW17020S) ,  Infectious diseases,parasitics diseases in general.  (GD01010H)

Substance index (3)： Aztreonam ,  Amikacin ,  Arbekacin

Reference (14)：

• 1. Tateda, K., Ishii, Y., Matsumoto, T., et al. (2006): 'Break-point Checkerboard Plate' for screening of appropriate antibiotic com-binations against multidrug-resistant Pseudomonas aeruginosa. Scand. J. Infect. Dis., 38, 268-272.
• 2. Sekiguchi, J., Asagi, T., Miyoshi-Akiyama, T., et al. (2007): Out-breaks of multidrug-resistant Pseudomonas aeruginosa in com-munity hospitals in Japan. J. Clin. Microbiol., 45, 979-989.
• 3. Docquier, J.D., Riccio, M.L., Mugnaioli, C., et al. (2003): IMP-12, a new plasmid-encoded metallo-β-lactamase from a Pseudomonas putida clinical isolate. Antimicrob. Agents Chemother., 47, 1522-1528.
• 4. Docquier, J.D., Lamotte-Brasseur, J., Galleni, M., et al. (2003): On functional and structural heterogeneity of VIM-type metallo-β-lactamases. J. Antimicrob. Chemother., 51, 257-266.
• 5. Araoka, H., Baba, M., Takagi, S., et al. (2010): Monobactam and aminoglycoside combination therapy against metallo-β-lac-tamase-producing multidrug-resistant Pseudomonas aeruginosa screened using a 'break-point checkerboard plate'. Scand. J. In-fect. Dis., 42, 231-233.

Terms in the title (6)： 日本 ,  多剤耐性 ,  Pseudomonas ,  アズトレオナム ,  アミノグリコシド ,  併用効果